Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
150 participants
INTERVENTIONAL
2021-02-01
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Synbiotics on the Upper Respiratory Tract Infection
NCT04960878
Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion
NCT03277820
Probiotic Chewables in Allergic Rhinoconjunctivitis Patients
NCT04898686
Clinical Trial to Evaluate the Efficacy of a Probiotic Preparation in the Prevention of Upper Respiratory Tract Infections in Adults
NCT07091955
Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).
NCT04937556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Verum Microbiome spray group
Daily use of microbiome spray for two weeks
Microbiome spray
Throat spray containing 3 beneficial lactobacilli strains
Placebo spray group
Daily use of placebo spray for two weeks
Placebo spray
Throat spray
Household member group
No use of spray
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microbiome spray
Throat spray containing 3 beneficial lactobacilli strains
Placebo spray
Throat spray
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Instructed during screening and agreed not to use other probiotic nutritional supplements outside of the study during the study period
* Sign the consent form
Exclusion Criteria
* Vaccinated against SARS-CoV-2 at start of the study (both for index patients and household members that participate)
* Pregnant women
* History of use of probiotic supplements in the past two weeks
* Current diagnosis of cancer or immunosuppressive therapy within the past 6 months
* Acute and chronic infectious and inflammatory upper airway diseases (eg acute / chronic rhinosinusitis)
* Clinically significant bleeding disorder
* Any other medical condition that, in the principal investigator's opinion, warrants exclusion from the trial
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Lebeer
Prof. dr.ir.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Veronique Verhoeven
Antwerp, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B3002021000018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.